These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 8056282

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Molecular characterization of TEM-59 (IRT-17), a novel inhibitor-resistant TEM-derived beta-lactamase in a clinical isolate of Klebsiella oxytoca.
    Bermudes H, Jude F, Chaibi EB, Arpin C, Bebear C, Labia R, Quentin C.
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1657-61. PubMed ID: 10390218
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum beta-lactamase-producing and extended-spectrum beta-lactamase-non-producing Escherichia coli isolates.
    López-Cerero L, Picón E, Morillo C, Hernández JR, Docobo F, Pachón J, Rodríguez-Baño J, Pascual A.
    Clin Microbiol Infect; 2010 Feb; 16(2):132-6. PubMed ID: 19614715
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Plasmid encoded beta-lactamases resistant to inhibition by clavulanic acid produced by calf faecal coliforms.
    Hunter JE, Corkill JE, McLennan AG, Fletcher JN, Hart CA.
    Res Vet Sci; 1993 Nov; 55(3):367-70. PubMed ID: 8284502
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Frequency of inhibitor-resistant TEM beta-lactamases in Escherichia coli isolates from urinary tract infections in France.
    Henquell C, Sirot D, Chanal C, De Champs C, Chatron P, Lafeuille B, Texier P, Sirot J, Cluzel R.
    J Antimicrob Chemother; 1994 Nov; 34(5):707-14. PubMed ID: 7706166
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Effects of Asp-179 mutations in TEMpUC19 beta-lactamase on susceptibility to beta-lactams.
    Vakulenko SB, Tóth M, Taibi P, Mobashery S, Lerner SA.
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1878-80. PubMed ID: 7486939
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. In vivo selection of a complex mutant TEM (CMT) from an inhibitor-resistant TEM (IRT) during ceftazidime therapy.
    Jacquier H, Marcadé G, Raffoux E, Dombret H, Woerther PL, Donay JL, Arlet G, Cambau E.
    J Antimicrob Chemother; 2013 Dec; 68(12):2792-6. PubMed ID: 23861309
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.